Xcout Intel
Ascletis Pharma Inc.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is based in Hangzhou, the People’s Republic of China.
Subscribe to see Ascletis Pharma Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ascletis Pharma Inc. at a glance
Ascletis Pharma Inc. is a biotech company headquartered in China. It is publicly listed (01672) with a market capitalisation of $1.5B. Xcout tracks 5 named people at Ascletis Pharma Inc., including Judy Hejingdao Wu (Executive Director).
Ascletis Pharma Inc. leadership
- Judy Hejingdao WuExecutive Director
- Jinzi J. WuFounder, Chairman, Executive Director and Chief Executive Officer
- Jiong GUIndependent Non-executive Director
- Lin HUAIndependent Non-executive Director
- Yizhen WEIIndependent Non-executive Director
Get Ascletis Pharma Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ascletis Pharma Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access